Icosapent Ethyl (Vascepa) Market Report

Icosapent Ethyl (Vascepa) Market Analysis: Clinical Adoption, Competitive Landscape, And Global Expansion, 2025 - 2033

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Icosapent ethyl (Vascepa) Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
                        3.3.3. Pipeline Analysis
                        3.3.4. Patent Expiry Analysis
                        3.3.5. Pricing Analysis
Chapter 4. Icosapent ethyl (Vascepa) Market: Indication Business Analysis
                    4.1. Indication Market Share, 2024 & 2033
                    4.2. Indication Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2021 to 2033 (USD Million)
                    4.4. Cardiovascular Risk-reduction
                        4.4.1. Cardiovascular Risk-reduction, 2021 - 2033 (USD Million)
                    4.5. Severe Hypertriglyceridemia
                        4.5.1. Severe Hypertriglyceridemia, 2021 - 2033 (USD Million)
                    4.6. Others
                        4.6.1. Others, 2021 - 2033 (USD Million)
Chapter 5. Icosapent ethyl (Vascepa) Market: Regional Estimates & Trend Analysis
                    5.1. Regional Market Share Analysis, 2024 & 2033
                    5.2. Regional Market Dashboard
                    5.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
                    5.4. North America
                    5.5. Europe
                    5.6. Asia Pacific
                    5.7. Latin America
                    5.8. Middle East and Africa
Chapter 6. Competitive Landscape
                    6.1. Company Profile
                        6.1.1. Amarin Pharma, Inc.
                            6.1.1.1. Overview
                            6.1.1.2. Financial Performance
                            6.1.1.3. Product Benchmarking
                            6.1.1.4. Strategic Mapping
                    6.2. Concurrent Competitive Landscape
                        6.2.1. GSK
                            6.2.1.1. Overview
                            6.2.1.2. Financial Performance
                            6.2.1.3. Product Benchmarking
                            6.2.1.4. Strategic Mapping
                        6.2.2. AstraZeneca
                            6.2.2.1. Overview
                            6.2.2.2. Financial Performance
                            6.2.2.3. Product Benchmarking
                            6.2.2.4. Strategic Mapping
                        6.2.3. Amgen
                            6.2.3.1. Overview
                            6.2.3.2. Financial Performance
                            6.2.3.3. Product Benchmarking
                            6.2.3.4. Strategic Mapping
                        6.2.4. Novartis
                            6.2.4.1. Overview
                            6.2.4.2. Financial Performance
                            6.2.4.3. Product Benchmarking
                            6.2.4.4. Strategic Mapping
                        6.2.5. Esperion Therapeutics
                            6.2.5.1. Overview
                            6.2.5.2. Financial Performance
                            6.2.5.3. Product Benchmarking
                            6.2.5.4. Strategic Mapping 


List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Icosapent ethyl (Vascepa) market, by region, 2021 - 2033 (USD Million)
Table 4 North America Icosapent ethyl (Vascepa) market, by Indication, 2021 - 2033 (USD Million)
Table 5 Europe Icosapent ethyl (Vascepa) market, by Indication, 2021 - 2033 (USD Million)
Table 6 Asia Pacific Icosapent ethyl (Vascepa) market, by Indication, 2021 - 2033 (USD Million)
Table 7 Latin America Icosapent ethyl (Vascepa) market, by Indication, 2021 - 2033 (USD Million)
Table 8 Middle East & Africa Icosapent ethyl (Vascepa) market, by Indication, 2021 - 2033 (USD Million)


List of Figures

Fig. 1 Icosapent ethyl (Vascepa) market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape
Fig. 10 Icosapent ethyl (Vascepa) market dynamics
Fig. 11 Icosapent ethyl (Vascepa) market: Porter’s five forces analysis
Fig. 12 Icosapent ethyl (Vascepa) market: PESTLE analysis
Fig. 13 Indication market, 2021 - 2033 (USD Million)
Fig. 14 Icosapent ethyl (Vascepa) market revenue, by region
Fig. 15 Regional marketplace: Key takeaways
Fig. 16 North America Icosapent ethyl (Vascepa) market, 2021 - 2033 (USD Million)
Fig. 17 Europe Icosapent ethyl (Vascepa) market, 2021 - 2033 (USD Million)
Fig. 18 Asia Pacific Icosapent ethyl (Vascepa) market, 2021 - 2033 (USD Million)
Fig. 19 Latin America Icosapent ethyl (Vascepa) market, 2021 - 2033 (USD Million)
Fig. 20 MEA Icosapent ethyl (Vascepa) market, 2021 - 2033 (USD Million)
Fig. 21 Company categorization
Fig. 22 Company market position analysis
Fig. 23 Strategic framework

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo